European HTA agencies launch the Heads of Agencies Group (HAG)
FDA-EMA Parallel Scientific Advice Pilot program for complex generic/hybrid products
Value-based pricing of prescription drugs benefits patients and promotes innovation
We provide an overview of the product life cycle